Holen Sie sich die Stockscreener-App
3.22
4.17%
-0.14
Rocket Pharmaceuticals Inc Aktie (RCKT) Neueste Nachrichten
Rocket Pharma falls on delay of certain drug development programs - TradingView
Rocket Pharmaceuticals (RCKT) Restructures, Cuts Workforce by 30% - GuruFocus
Rocket Pharmaceuticals cuts headcount, realigns pipeline (RCKT:NASDAQ) - Seeking Alpha
The Fragile Equilibrium: Assessing Rocket Pharmaceuticals Amid Securities Litigation and Governance Concerns - AInvest
Rocket Pharmaceuticals (RCKT) Restructures for Strategic Focus a - GuruFocus
Rocket Pharmaceuticals Announces Strategic Reorganization - TipRanks
Rocket Pharmaceuticals cuts workforce by 30% to focus on heart therapies - Investing.com Australia
Rocket Pharmaceuticals Announces Strategic Corporate Reorganizat - GuruFocus
Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs - Business Wire
FDA Clinical Hold on RP-A501 Trial Triggers Rocket - GlobeNewswire
Rocket Pharmaceuticals Announces Strategic Reorganization Plan - TipRanks
Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Join Class Action Before August 11, 2025Contact Levi & Korsinsky - Barchart.com
Investor Alert: Securities Class Action Filed Against Rocket Pharmaceuticals (RCKT) - TradingView
RCKT Class Action Reminder: Robbins LLP Reminds Rocket Pharmaceuticals, Inc. Investors of the Class Action LawsuitContact us for more information - PR Newswire
RCKT INVESTOR ALERT: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
RCKT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RCKT To Contact Him Directly To Discuss Their Options - PR Newswire
Signaturefd LLC Increases Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharmaceuticals Inc. Equity Warrant Stock Analysis and ForecastMarket-leading capital gains - Autocar Professional
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals - StreetInsider
Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. (RCKT) Shareholders of Class Action Lawsuit and August 11, 2025 Deadline - Barchart.com
Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Safety Disclosures and Stock Drop - TradingView
ROSEN, A TOP RANKED LAW FIRM, Encourages Rocket - GlobeNewswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCKT - GlobeNewswire Inc.
FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class ActionHagens Berman - TradingView
Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
What drives Rocket Pharmaceuticals Inc. Equity Warrant stock priceTremendous growth potential - jammulinksnews.com
Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Join - GlobeNewswire
ROCKET PHARMACEUTICALS, INC. (NASDAQ: RCKT) SHAREHOLDER - GlobeNewswire
What analysts say about Rocket Pharmaceuticals Inc. Equity Warrant stockExceptional growth trajectory - Autocar Professional
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
Rocket Pharmaceuticals Inc (RCKT) Stock: Navigating a Year of Stock Volatility - investchronicle.com
Class Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT)August 11, 2025 Deadline to JoinContact The Gross Law Firm - PR Newswire
INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Is Rocket Pharmaceuticals Inc. a good long term investmentAccelerated capital growth - jammulinksnews.com
Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Contact Levi & Korsinsky to Join Class Action Before August 11, 2025 - ACCESS Newswire
2025-07-20 | Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Contact Levi & Korsinsky to Join Class Action Before August 11, 2025 | NDAQ:RCKT | Press Release - Stockhouse
What analysts say about Rocket Pharmaceuticals Inc. stockRapid-fire capital growth - jammulinksnews.com
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire
2025-07-20 | RCKT LAWSUIT ALERT: Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. InvestorsLead Plaintiff Deadline August 11, 2025 | NDAQ:RCKT | Press Release - Stockhouse
2025-07-19 | RCKT ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Rocket Pharmaceuticals, Inc.August 11, 2025 Deadline | NDAQ:RCKT | Press Release - Stockhouse
What drives Rocket Pharmaceuticals Inc. stock priceHigh-profit trading signals - Jammu Links News
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Rocket - GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals - StreetInsider
Rocket Pharmaceuticals Inc. Stock Analysis and ForecastFree Wealth Planning Blueprint - jammulinksnews.com
Is Rocket Pharmaceuticals Inc. Equity Warrant a good long term investmentUnrivaled growth potential - jammulinksnews.com
2025-07-18 | Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Join Class Action Before August 11, 2025Contact Levi & Korsinsky | NDAQ:RCKT | Press Release - Stockhouse
Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Contact Levi & Korsinsky Before August 11, 2025 to Join Class Action - TradingView
Deadline Alert: Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire
Class Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT) Seeking Recovery for InvestorsContact Levi & Korsinsky - PR Newswire
3.50%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):